Skip to main content

Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA is a major global healthcare company dedicated to providing high-quality products and specialized services for hospital operations, outpatient care, and complex medical procedures worldwide. The enterprise operates through two main business segments: Fresenius Kabi, which focuses on life-saving medicines, clinical nutrition solutions, infusion technologies, and intravenous devices, and Fresenius Helios, which manages a dominant network of private hospitals across Germany and Spain. Furthermore, the group retains a major equity stake in Fresenius Medical Care, a global leader in providing dialysis equipment, renal pharmaceuticals, and specialized care services for chronic kidney disease patients. The company's revenues are primarily derived from worldwide demand for essential pharmaceuticals, acute inpatient treatments, elective surgical care, and chronic medical management across expanding demographics. Operating on a massive global scale with hundreds of thousands of employees, the healthcare group manages dozens of production sites and acute facilities across multiple continents. Headquartered in Bad Homburg vor der Höhe, Germany, the company maintains its primary public equity listing on the Frankfurt Stock Exchange and is a core constituent of the DAX stock index.

75 of the funds FundTelligence covers report a position in Fresenius SE & Co KGaA.

Legal name
FRESENIUS SE & CO KGAA
Sector
Health Care
Country
Germany
Funds holding it
75
Exposure themes
Ageing & Longevity, Age-Related Disease, Renal Care

Funds holding Fresenius SE & Co KGaA

Showing the 8 largest of 75 funds holding it.

Loading...